Skip to content
healthcare.dev

BRIMONIDINE

NDC 45802-078, brimonidine, gel, from Padagis Israel Pharmaceuticals Ltd.

Product NDC
45802-078
Status
Listed
Labeler
Padagis Israel Pharmaceuticals Ltd
Dosage form
GEL
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209158
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45802-078 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BRIMONIDINE TARTRATE5 mg/g

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
45802-078-30458020078301 BOTTLE, PUMP in 1 CARTON (45802-078-30) / 30 g in 1 BOTTLE, PUMP

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c899b329-cc5e-4443-8e94-451314de47c9
  • NADAC price for package 45802007830

    GET /v1/drugs/nadac/45802007830

Use it

Look up 45802-078 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45802-078 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45802-078. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.